- Home
- VHC vs IBIO Comparison
VHC vs IBIO Comparison
Compare VHC & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHC
- IBIO
- Stock Information
- Founded
- VHC 2005
- IBIO 2008
- Country
- VHC United States
- IBIO United States
- Employees
- VHC N/A
- IBIO N/A
- Industry
- VHC Multi-Sector Companies
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- VHC Miscellaneous
- IBIO Health Care
- Exchange
- VHC Nasdaq
- IBIO Nasdaq
- Market Cap
- VHC 26.2M
- IBIO 23.4M
- IPO Year
- VHC 1999
- IBIO N/A
- Fundamental
- Price
- VHC $5.85
- IBIO $2.30
- Analyst Decision
- VHC
- IBIO Strong Buy
- Analyst Count
- VHC 0
- IBIO 2
- Target Price
- VHC N/A
- IBIO $4.30
- AVG Volume (30 Days)
- VHC 6.0K
- IBIO 97.9K
- Earning Date
- VHC 11-13-2024
- IBIO 11-12-2024
- Dividend Yield
- VHC N/A
- IBIO N/A
- EPS Growth
- VHC N/A
- IBIO N/A
- EPS
- VHC N/A
- IBIO N/A
- Revenue
- VHC $5,000.00
- IBIO $175,000.00
- Revenue This Year
- VHC N/A
- IBIO N/A
- Revenue Next Year
- VHC N/A
- IBIO N/A
- P/E Ratio
- VHC N/A
- IBIO N/A
- Revenue Growth
- VHC N/A
- IBIO 250.00
- 52 Week Low
- VHC $3.55
- IBIO $0.25
- 52 Week High
- VHC $9.44
- IBIO $6.20
- Technical
- Relative Strength Index (RSI)
- VHC 30.31
- IBIO 40.07
- Support Level
- VHC $5.87
- IBIO $2.40
- Resistance Level
- VHC $6.08
- IBIO $2.65
- Average True Range (ATR)
- VHC 0.21
- IBIO 0.21
- MACD
- VHC -0.01
- IBIO -0.07
- Stochastic Oscillator
- VHC 13.70
- IBIO 27.49
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services, and critical infrastructures.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.